Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 29, 2019
Cash Flows from Operating Activities
Net loss	$ (4,473)	$ (9,077)
Adjustments to reconcile net loss to net cash provided by operating activities:
Impairment of goodwill	0	6,760
Inventory allowance	0	1,742
Depreciation and amortization	5,211	5,140
Amortization of debt issuance costs	111	133
Loss on sale of assets	118	5
Loss on derivative instrument	469	746
Stock option expense	88	117
Deferred income taxes	(1,538)	(1,073)
Changes in operating assets and liabilities that provided (used) cash:
Accounts receivable	(2,300)	2,978
Inventory	635	11
Prepaid expenses and other assets	(2,629)	(646)
Accounts payable	3,563	336
Accrued and other liabilities	(395)	(259)
Other, net	1,789	0
Net cash provided by operating activities	649	6,913
Cash Flows from Investing Activities
Capital expenditures	(1,533)	(2,129)
Proceeds from sale of property, plant and equipment	883	41
Net cash used in investing activities	(650)	(2,088)
Cash Flows from Financing Activities
Net change in bank overdraft	(289)	1,003
Payments on term loans and capital expenditure line	(2,186)	(3,012)
Payments on revolving credit facilities	(19,281)	(21,998)
Distribution of cash dividends	0	(489)
Debt issuance costs	(151)	0
Net cash provided by (used in) financing activities	1,622	(4,708)
Cash and cash equivalents:
Net increase in cash and cash equivalents	1,621	117
Cash and cash equivalents at beginning of period	650	1,410
Cash and cash equivalents at end of period	2,271	1,527
Supplemental disclosure of cash flow information:
Cash paid for interest	3,034	3,442
Cash paid for Income taxes	329	357
Line of credit for capital expenditures
Cash Flows from Financing Activities
Proceeds from lines of credit	0	1,300
Revolving credit facility
Cash Flows from Financing Activities
Proceeds from lines of credit	17,530	18,488
Proceeds from PPP Note	$ 5,999	$ 0